Ros Cheetham

Ros Cheetham has a diverse and extensive work experience in the pharmaceutical industry. Ros has held various leadership roles in renowned companies such as MacroGenics, Inc., WIRB-Copernicus Group, Tosto Consulting LLC, Allergan, GlaxoSmithKline, Johnson & Johnson Pharmaceutical Research and Development, Janssen Research Foundation, Janssen-Cilag, and Ciba-Geigy.

In their most recent role as Vice President of Clinical Operations at MacroGenics, Inc., they are responsible for overseeing clinical operations. Prior to this, they served as Senior Vice President at WIRB-Copernicus Group, where they provided cross-functional support to the Business Development (BD) organization and helped determine the needs of clients.

As the President of Tosto Consulting LLC, Ros Cheetham offered strategic and operational consulting services in areas such as global clinical operations solutions, global drug development, and partnership/alliance strategy.

During their tenure as Vice President of Global Clinical Operations at Allergan, they had global accountability for operationalizing the company's portfolio, including multiple therapeutic areas. Ros delivered significant cost savings through organizational restructuring and process efficiencies.

At GlaxoSmithKline, Ros held various leadership roles, including Vice President and Medicines Development Leader in Rare Diseases, Vice President and Medicines Development Leader in Neurosciences, Vice President of the Global Clinical Operations Neurosciences Medicines Development Center, and Vice President of North American Global Clinical Operations. Ros was responsible for the successful development, commercialization, and life cycle management of assets in late-stage development, as well as the delivery of clinical trials within specified timelines and budgets.

Ros also gained valuable experience at Johnson & Johnson Pharmaceutical Research and Development, where they served as Senior Director of R&D Process Excellence and Change Management. Additionally, at Janssen Research Foundation, they held roles such as Director of Operations Officer, Clinical Operations Team Management, Director of Global Clinical Operations, and Associate Director of Clinical Research, Development & Regulatory Affairs, Worldwide, CNS.

Early in their career, Ros worked at Janssen-Cilag as a Medical Research Manager and Clinical Research Associate. Ros was responsible for international development and clinical trials related to schizophrenia and other indications.

Before their career in the pharmaceutical industry, Ros worked as a Medical Representative and Trade Marketing Specialist at Ciba-Geigy.

Overall, Ros Cheetham's work experience exemplifies their expertise in clinical operations, strategic partnerships, consulting, organizational leadership, and delivering successful outcomes in the pharmaceutical industry.

Ros Cheetham completed their undergraduate education from 1976 to 1979 at Imperial College London, where they earned a BSc (Honours) degree in Zoology. In 1981, they enrolled at the University of the Witwatersrand and obtained a Master of Science (MSc) degree in Zoology/pharmacology, specifically focusing on the treatment of C. hepatica infection. Later in 1986, they attended Damelin College of Marketing Management in South Africa, where they received a Certificate of Marketing Management, specializing in Marketing.